CFO
ABBV icon

Custos Family Office’s AbbVie ABBV Stock Holding History

Custos Family Office’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$292K Sell
1,278
-212
-14% -$48.3K 0.2% 52
2025
Q3 		$345K Buy
1,490
+112
+8% +$22.8K 0.2% 49
2025
Q2 		$256K Buy
1,378
+236
+21% +$43.9K 0.08% 65
2025
Q1 		$239K Buy
+1,142
New +$222K 0.08% 60

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Custos Family Office's ABBV Position: Q4 2025 in Review

Custos Family Office reduced its AbbVie (ABBV) stake by 14% in Q4 2025, selling an estimated $48.3K and leaving 1,278 shares worth $292K. The position accounts for 0.2% of the portfolio, ranked #52.

Custos Family Office first reported a position in ABBV in Q1 2025 and has held it in 4 quarters since. The position peaked at $345K in Q3 2025. 4,147 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

  • Custos Family Office held 1,278 shares of AbbVie worth $292K as of Q4 2025.
  • Custos Family Office sold 212 AbbVie shares in Q4 2025, an estimated $48.3K.
  • AbbVie made up 0.2% of Custos Family Office's portfolio in Q4 2025, its #52 holding.
  • Custos Family Office first reported a position in AbbVie in Q1 2025 and has held it in 4 quarters since.
  • Custos Family Office's AbbVie position peaked at $345K in Q3 2025.
  • 4,147 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on Custos Family Office's 13F filing for Q4 2025, filed 17 Feb 2026.